<DOC>
	<DOCNO>NCT03040908</DOCNO>
	<brief_summary>The 6-minute walk ( 6MWT ) test use adult child affect wide range chronic disease evaluate sub-maximal exercise capacity . It reflect global response various physiological system ( respiratory , cardio-vascular , neurologic , metabolic musculosquelettic ) situation simulate daily life activity . In child sickle cell disease , 6MWT correlate low level hemoglobin , low level fetal hemoglobin low red cell deformability . Our team previously report population child sickle cell disease , highly treated hydroxyurea , sole factor independently link 6MWT presence silence infarct . As cardio-vascular cerebro-vascular injury sickle cell disease directly correlate hemolysis , investigator aim evaluate ) clinical relevance endothelial inflammation parameter new hemolysis marker b ) presence silent infarct 6MWT correlate biological marker . This cross-sectional study include sickle cell disease patient regularly follow 5 year Hôpital Universitaire des Enfants Reine Fabiola , Centre Hospitalier Universitaire ( CHU ) -Brugmann , Centre Hospitalier Etterbeek-Ixelles , CHU Saint-Pierre , Cliniques Universitaires Saint-Luc ( Bruxelles , Belgium ) . Inclusion criterion : sickle cell disease ( SS , Sbeta° , SC , Sbeta+ ) , age range : 6 25 year , sign informed consent . Exclusion criterion : transplant patient , inability perform 6MWT ( severe cognitive disability , femoral osteonecrosis functional impairment ) , hospitalization and/ transfusion last 3 month acute event . Demographic data clinical data retrospectively record . Blood test 6MWT perform steady state . Studied analysis : coagulation factor , free hemoglobin , Pro-B type natriuretic peptide ( Pro-BNP ) , High sensitivity C reactive protein ( HS-CRP ) , Intercellular Adhesion Molecule ( ICAM ) , Vascular Cell Adhesion Molecule ( VCAM ) Selectins . With study , investigator expect validate new predictive marker cardio-vascular cerebrovascular injury identify patient high risk develop complication .</brief_summary>
	<brief_title>New Hemolysis Parameters Sickle Cell Disease</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<criteria>Sickle Cell Disease ( HbSS , S beta° , S beta+ , SC ) Regular followup 5 year Written inform consent Transplanted patient Hospitalisation acute event within 3 month Acute transfusion within 3 month Unable perform 6minute walk test</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>